NOT-DA-25-040: Notice to Expire RFA-DA-26-002, "Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed)"

Notice to Expire RFA-DA-26-002, "Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed)"

Notice Number:

NOT-DA-25-040

Key Dates

Release Date:

November 20, 2025

Related Announcements

March 19, 2026- Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed). See NOFO RFA-DA-26-001
March 19, 2026- Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed). See NOFO RFA-DA-26-002

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice alerts applicants of the early expiration of RFA-DA-26-002 “Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed). The request for applications, RFA-DA-26-002, will be expired, effective immediately. No further applications will be accepted for consideration under this NOFO.

Applicants are encouraged to consider applying to the Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed). See NOFO RFA-DA-26-001

Inquiries

Please direct all inquiries to:

John Satterlee, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1020
Email: [email protected]